Strata Critical Medical, Inc. (SRTA) Tops Q1 EPS by 6c, reiterates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SRTA Hot Sheet
Join SI Premium – FREE
Strata Critical Medical, Inc. (NASDAQ: SRTA) reported Q1 EPS of $0.03, $0.06 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.4 million versus the consensus estimate of $63.68 million.
GUIDANCE:
Strata Critical Medical, Inc. sees FY2026 revenue of $260-275 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Strata Critical Medical, Inc. (SRTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tapestry (TPR) Tops Q1 EPS by 26c; offers guidance
- Evergy (EVRG) Tops Q3 EPS by 38c
- Evolent Health (EVH) Reports In-Line Q3 EPS ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
